Aminopyrimidine compound as cdk2/4/6 triple inhibitor
AssigneeCisen Pharmaceutical Co., Ltd.
InventorsMing ZHOU, Zhaobing XU, Gang LI, Lihong HU, Charles Z. DING, Wen JIANG, Guoping HU, Jian LI, Shuhui CHEN
Life of this patent
Estimating the term…
Loading patent…
AssigneeCisen Pharmaceutical Co., Ltd.
InventorsMing ZHOU, Zhaobing XU, Gang LI, Lihong HU, Charles Z. DING, Wen JIANG, Guoping HU, Jian LI, Shuhui CHEN
Estimating the term…
Disclosed is an aminopyrimidine compound as a CDK2/4/6 inhibitor, and specifically disclosed are the compound represented by formula (I) and a pharmaceutically acceptable salt thereof, and an application of the compound represented by formula (I) and the pharmaceutically acceptable salt thereof in the preparation of a medicament for treating solid tumor.
A compound represented by formula (I) or a pharmaceutically acceptable salt thereof,
8-13. (canceled)
(canceled)
(canceled)
A compound of the following formula or a pharmaceutically acceptable salt thereof:
A compound of the following formula or a pharmaceutically acceptable salt thereof:
Dependencies are inferred from the claim text.